
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **MS4A1 (CD20)**: A well-known marker for B cells, involved in B cell activation and proliferation.<br>- **CD79A and CD79B**: Components of the B cell receptor (BCR) complex, crucial for B cell development and signaling.<br>- **IGKC, IGHM, IGLC2**: Immunoglobulin components, indicating antibody production, characteristic of B cells.<br>- **HLA-DRA, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRB1**: Major histocompatibility complex (MHC) class II molecules, important for antigen presentation, typically expressed in antigen-presenting cells, including B cells.<br>- **IRF8**: A transcription factor involved in the development and function of immune cells, including B cells.<br>- **POU2F2 (OCT2) and POU2AF1 (BOB1)**: Transcription factors involved in B cell differentiation and function.<br>- **CD19, CD22, CD37, CD53, CD74**: Surface markers associated with B cells, involved in various signaling pathways.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MS4A1 (CD20), CD19, CD22**: Classic B cell markers.<br>- **VPREB3**: Part of the pre-B cell receptor complex, indicating early B cell development.<br>- **BANK1**: B cell scaffold protein with ankyrin repeats, involved in B cell receptor signaling.<br>- **TNFRSF13C (BAFF-R)**: A receptor for BAFF, crucial for B cell survival.<br>- **RAC2, LCP1, CXCR4**: Involved in cell migration and signaling, often expressed in B cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas, CellMarker, and literature on scRNA-seq data, the markers listed are predominantly associated with B cells. The presence of immunoglobulin components, BCR complex proteins, and MHC class II molecules strongly supports this.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **B cells**. The presence of key B cell markers such as MS4A1, CD19, CD79A, and immunoglobulin components strongly indicates this.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Naive B Cells**: Characterized by the expression of CD19, CD20 (MS4A1), and the absence of class-switched immunoglobulins.<br>2. **Memory B Cells**: Express CD19, CD20, and may have class-switched immunoglobulins, but the dataset lacks specific class-switch markers.<br>3. **Plasma Cells**: While some immunoglobulin components are present, the lack of high expression of plasma cell-specific markers like CD138 (SDC1) makes this less likely.<br><br>The most likely subtype based on the markers is **Naive B Cells**, given the presence of early B cell markers like VPREB3 and the absence of class-switching indicators.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of B cells. The expression of key B cell markers such as MS4A1, CD19, CD79A, and immunoglobulin components supports this conclusion. Among B cells, the most probable subtype is Naive B Cells, given the presence of early B cell development markers and the absence of class-switched immunoglobulins.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. The markers listed in the annotation result are present in the provided marker list, and they are well-known markers for B cells. The analysis correctly identifies the cell type as B cells, supported by the presence of key B cell markers such as MS4A1, CD19, CD79A, and immunoglobulin components. The consideration of subtypes, particularly Naive B Cells, is appropriate given the presence of early B cell development markers like VPREB3 and the absence of class-switched immunoglobulins. There is no strong evidence of mixed cell types based on the provided markers, so the annotation is valid.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">B cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Naive B Cells</li><li>Memory B Cells</li><li>Plasma Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the markers associated with B cells, particularly in the context of a breast cancer tissue dataset. The analysis correctly identifies the main cell type as B cells, supported by the presence of key markers such as MS4A1 (CD20), CD19, and CD79A, which are classic indicators of B cell identity. The inclusion of immunoglobulin components and MHC class II molecules further supports this classification.<br><br>The annotation process shows a balanced consideration of multiple markers, rather than over-focusing on a single one. For instance, the analysis takes into account both surface markers (e.g., CD19, CD22) and functional markers (e.g., IGKC, IGHM) to arrive at the conclusion. This comprehensive approach ensures that the general picture of the cell population is captured accurately.<br><br>The identification of subtypes, particularly Naive B Cells, is well-reasoned given the presence of early B cell development markers like VPREB3 and the absence of class-switched immunoglobulins. The consideration of Memory B Cells and Plasma Cells as potential subtypes, despite the lack of strong evidence for class-switching or plasma cell-specific markers, shows a thorough exploration of possibilities without making unsupported claims.<br><br>One potential area for improvement could be a more explicit discussion of the rank and relative importance of the markers, as the order of marker appearance can provide additional insights into their significance. However, the overall analysis remains scientifically accurate and provides a comprehensive view of the cell types present.<br><br>There are no obvious misclassifications or oversights in the annotation, and the validation step confirms the correctness of the results. The annotation effectively captures the general picture of the cell populations within the dataset.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    